1551. Changes in Glomerular Filtration Rate after Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide Fumarate for HIV Pre-exposure Prophylaxis

BACKGROUND: In October 2019, tenofovir alafenamide fumarate (TAF) was approved for oral pre-exposure prophylaxis (PrEP) for preventing human immunodeficiency virus (HIV) infection. Compared with tenofovir disoproxil fumarate (TDF), TAF-containing regimens have demonstrated high efficacy and favorabl...

Descripción completa

Detalles Bibliográficos
Autores principales: Rivera, Adovich, Mefford, Matthew, Pak, Katherine J, Hechter, Rulin C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678373/
http://dx.doi.org/10.1093/ofid/ofad500.1386

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678373/
http://dx.doi.org/10.1093/ofid/ofad500.1386

Ejemplares similares